| abstract |
The present invention provides a method for improving the bioavailability of a renin inhibitor, preferably an amide derivative of the acid (-amino - (- hydroxy - (- aryl-alkanoic acid), the method of which comprises co-administering to a mammal, in especially to a human being, who needs treatment, a combination of a renin inhibitor, or a pharmaceutically acceptable salt thereof, and an effusion protein inhibitor. |